Wielding Microbe Against Microbe - New Antibiotic Discovered
Main Category: Infectious Diseases / Bacteria / VirusesAlso Included In: Biology / Biochemistry; Cancer / Oncology
Article Date: 03 Oct 2008 - 4:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
As the southern pine beetle moves through the forest boring tunnels inside the bark of trees, it brings with it both a helper and a competitor. The helper is a fungus that the insect plants inside the tunnels as food for its young. But also riding along is a tiny, hitchhiking mite, which likewise carries a fungus for feeding its own larvae.
Now the picture of this peculiar, millennia-old arrangement has grown even more curious. Writing in the Oct. 3 issue of Science, a team of researchers reports that the pine beetle harnesses a second microorganism - a bacterium known as an actinomycete - to protect its fungus from the mite's competing one. What's more, the bacterium does so by wielding an antibiotic that is brand new to science.
The isolation of the novel antifungal compound - dubbed mycangimycin for the specialized compartments, or mycangia, in which the beetles carry both their fungi and bacteria - raises the intriguing possibility that other such discoveries could follow.
"There are perhaps 10 million species of insects on the planet," says University of Wisconsin-Madison evolutionary biologist and symbiosis expert, Cameron Currie, who led the study with Harvard University chemist Jon Clardy. "So, if insects associate with actinomycetes like this more generally, then there's potentially a huge number of new places to explore."
The realization couldn't come at a better time. Historically, the greatest source of antibiotics in the world has been the actinomycetes, especially members of the genus Streptomyces. But in recent years, the number of new compounds successfully isolated from these organisms - and indeed from all microbes - has dwindled, even as resistance to existing antibiotics has spread.
Whether symbiotic associations end up being a treasure trove of new antimicrobials and other useful agents remains to be seen. But it's promising to see insects pairing up with actinomycetes.
"Actinomycetes are likely very attractive in these situations because of their potent antibiotic-producing abilities," says UW-Madison graduate student, Jarrod Scott, who works with Currie. "In much the same way that we recognize the power of these microorganisms, I think other organisms, in an evolutionary sense, have also recognized their power."
Currie also has good reason to suspect these interactions are widespread. In the 1990s, he was the first to discover that a fungus-farming ant, the leaf-cutter, used an actinomycete to protect its fungal crop from a parasitic mold. That got him thinking about the importance of parasites and disease in the evolution of all organisms, and how these pressures may have led many insects to team up with beneficial microbes as a defense.
Beyond the leaf-cutting ants and pine beetles, one other example of this type of relationship is now established. "But it hasn't been systematically examined," says Currie. "If we actually start to look, we may find these associations to be very common."
That one of the pine's most devastating enemies in the southern United States and Mexico relies so heavily on a bacterium seems incredible, but that's precisely the case for the southern pine beetle. If the beetle's fungus, Entomocorticium, is outgrown by the mite's fungal partner, Ophiostoma, the beetle larvae will starve. Holding Ophiostoma in check has therefore become the job of the actinomycete.
What's interesting about the small molecule antibiotic it produces, though, is that it doesn't seem to target Ophiostoma specifically. The researchers instead suspect Entomocorticium has developed some resistance over time, says Scott, allowing it to survive the same low doses of antibiotic that wipe out its competitor.
This suggests the antibiotic could have broad-spectrum activity against other fungi and parasites, a possibility the team is now investigating. And the discovery of a novel antifungal compound is especially exciting because many of these agents can serve double-duty as anticancer drugs, says Currie.
But for him and Scott, the greatest outcome would be wider recognition of the crucial role microbes play in the lives of all plants and animals, not just as parasites, but frequently as partners.
"Organisms like the pine beetle wouldn't be able to do what they do without microbes," says Scott. "So, we're interested in microorganisms as the basis of their success."
###
The study's other authors are Dong-Chan Oh of Harvard, M. Cetin Yuceer of Mississippi State University and Kier Klepzig of the U.S. Forest Service. Currie's work was funded by the USDA and the National Science Foundation.
Source: Jarrod Scott
University of Wisconsin-Madison
Visit our infectious diseases / bacteria / viruses section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/124141.php>
APA
http://www.medicalnewstoday.com/releases/124141.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




